Article Versions Notes

Bendix M, Dige A, Jørgensen SP, Dahlerup JF, Bibby BM, Deleuran B, Agnholt J. Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up. Nutrients. 2021; 13(4):1083. https://doi.org/10.3390/nu13041083

Bendix, Mia, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, and Jørgen Agnholt. 2021. "Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up" Nutrients 13, no. 4: 1083. https://doi.org/10.3390/nu13041083

Bendix, M., Dige, A., Jørgensen, S. P., Dahlerup, J. F., Bibby, B. M., Deleuran, B., & Agnholt, J. (2021). Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up. Nutrients, 13(4), 1083. https://doi.org/10.3390/nu13041083